Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
Analytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
Professional Services
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
Trust and Security
PatentBench
LLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Explore the Lyme disease vaccine pipeline — VLA15 Phase 3, Sanofi mRNA, OspA chimeras, and PTLDS diagnostics. Patent-driven analysis from PatSnap Insights.
Article | Report Explore the 2026 retinal prosthesis patent landscape: electronic, photovoltaic, and cell-based approaches restoring vision in RP and AMD patients. Key IP signals analysed.
Article | Report How acoustic metamaterial architectures — from phononic crystals to programmable cell arrays — achieve broadband noise attenuation in aircraft cabin panels. 50+ patents analysed.
Article | Report Patent analysis of NaV1.7 inhibitors, CGRP antagonists, and non-opioid chronic pain drug pipeline strategies from Pfizer, Regeneron, Lundbeck, and more.
Article | Report A 2026 patent landscape survey of hybrid rocket propulsion: solid-liquid combustion architectures, low-hazard oxidizers, trans-medium propulsion, and eVTOL hybrid powertrains.
Article | Report How coupled electro-thermal-mechanical simulation replaces physical prototype iterations in power electronics thermal design. Patent analysis across 40+ filings.
Article | Report How to design a closed-loop drug delivery system for automated insulin dosing in type 1 diabetes: patent intelligence covering MPC, PID, IOB, safety, and hardware.
Article | Report Map the 2026 acoustic metamaterial patent landscape: key assignees, broadband silencer innovations, active programmable cells, and strategic IP white space. 8 min read.
Article | Report How to design a closed-loop drug delivery system for automated insulin dosing in type 1 diabetes — patent intelligence covering MPC, PID, IOB, and safety architectures.
Article | Report PCM patent landscape 2026: Samsung, IBM, Intel & TSMC race to embed phase change memory in AI accelerators and 3D crossbar arrays. Full analysis inside.
Article | Report How continuous manufacturing replaces batch processing in pharmaceutical solid dosage production — patent intelligence analysis of key mechanisms, IP holders, and quality control innovations.
Article | Report A deep-dive patent landscape analysis of alkaline water electrolyzer technology in 2026: key assignees, membrane innovations, green hydrogen trends, and emerging application domains.
Article | Report Explore the PTSD drug pipeline: MDMA-assisted therapy, 5-MeO-DMT, PDE inhibitors, and emerging combination strategies. Patent intelligence from PatSnap Eureka.
Article | Report How impedance control differs from position control in physical human-robot interaction safety — patent intelligence from 50+ records across Franka Emika, Panasonic, GM, KUKA & more.
Article | Report A deep-dive patent landscape of alkaline water electrolyzer technology in 2026: key assignees, membrane innovations, green hydrogen trends, and strategic IP implications.